What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?-Reference-Cited by-同舟云学术

What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

Published:2023-05-13 Issue:7 Volume:25 Page:343-350
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Otieno Beryl,Ibecheozor Chukwuka,Williams Marlene S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11883-023-01108-z.pdf

Reference46 articles.

1. Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. Jama. 2022;327(7):662–75.

2. Anderson HV, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, et al. 2022 ACC/AHA key data elements and definitions for chest pain and acute myocardial infarction. J Am College Cardiol. 2022;80(17):1660–700.

3. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2019;41(3):407–77.

4. Bianco M, Careggio A, Destefanis P, Luciano A, Perrelli MG, Quadri G, et al. P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients. Eur Heart J - Cardiovasc Pharmacother. 2020;7(3):196–205.

5. Feng WH, Hsieh IC, Li YH. P2Y12 inhibitor monotherapy after percutaneous coronary intervention: is it safe to abandon aspirin? Acta Cardiol Sin. 2021;37(1):1–8.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scutellarin alleviates tensile stress-induced proliferation and migration of venous smooth muscle cells via mediating the p38 MAPK pathway;Tissue and Cell;2024-04

2. Long-term patency of aorto-biiliac endoprosthesis for critical lower limb ischaemia in Takayasu arteritis after complicated angioplasty with a drug-coated balloon: Effect of dual antiplatelet therapy combined with tocilizumab;Modern Rheumatology Case Reports;2023-06-03